Bartlett & CO. Wealth Management LLC Sells 10,705 Shares of CVS Health Co. (NYSE:CVS)

Bartlett & CO. Wealth Management LLC reduced its position in shares of CVS Health Co. (NYSE:CVS) by 28.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 26,650 shares of the pharmacy operator’s stock after selling 10,705 shares during the quarter. Bartlett & CO. Wealth Management LLC’s holdings in CVS Health were worth $1,196,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in CVS. MidAtlantic Capital Management Inc. acquired a new stake in CVS Health in the 3rd quarter valued at $25,000. Ridgewood Investments LLC lifted its stake in shares of CVS Health by 255.7% in the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 450 shares in the last quarter. Livelsberger Financial Advisory acquired a new position in shares of CVS Health during the third quarter valued at about $31,000. Legacy Investment Solutions LLC acquired a new stake in shares of CVS Health in the 3rd quarter worth about $31,000. Finally, Reston Wealth Management LLC bought a new position in CVS Health in the 3rd quarter valued at about $32,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

Shares of CVS opened at $53.87 on Friday. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $80.75. The stock’s 50-day simple moving average is $51.23 and its 200 day simple moving average is $56.24. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The stock has a market capitalization of $67.79 billion, a price-to-earnings ratio of 13.67, a price-to-earnings-growth ratio of 0.80 and a beta of 0.59.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The company had revenue of $95.43 billion during the quarter, compared to analyst estimates of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. CVS Health’s revenue was up 6.3% compared to the same quarter last year. During the same period last year, the business earned $2.21 earnings per share. Research analysts forecast that CVS Health Co. will post 5.22 EPS for the current fiscal year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be given a dividend of $0.665 per share. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a $2.66 annualized dividend and a yield of 4.94%. CVS Health’s payout ratio is presently 67.51%.

Analyst Ratings Changes

Several analysts have recently commented on the company. Wells Fargo & Company raised CVS Health from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $60.00 to $66.00 in a research note on Monday, November 18th. Barclays dropped their price objective on CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a research note on Thursday, November 7th. Mizuho reduced their target price on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research note on Thursday, October 24th. Royal Bank of Canada dropped their price target on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research report on Friday, November 15th. Finally, TD Cowen upped their price objective on shares of CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a research report on Monday, November 25th. One analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and an average target price of $68.71.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.